共 50 条
[1]
Pepys M.B., Hirschfield G.M., C-reactive protein: A critical update, J Clin Invest, 111, pp. 1805-1812, (2003)
[2]
Suleiman M., Khatib R., Agmon Y., Et al., Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: Predictive role of C-reactive protein, J Am Coll Cardiol, 47, pp. 962-968, (2006)
[3]
Ridker P.M., Cushman M., Stampfer M.J., Et al., Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med, 336, pp. 973-979, (1997)
[4]
Ridker P.M., Rifai N., Rose L., Et al., Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events, N Engl J Med, 347, pp. 1557-1565, (2002)
[5]
Danesh J., Whincup P., Walker M., Et al., Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses, BMJ, 321, pp. 199-204, (2000)
[6]
Ridker P.M., Clinical application of C-reactive protein for cardiovascular disease detection and prevention, Circulation, 107, pp. 363-369, (2003)
[7]
Ridker P.M., Cardiology Patient Page. C-reactive protein. A simple test to predict risk of heart attack and stroke, Circulation, 108, (2003)
[8]
Pearson T.A., Mensah G.A., Alexander R.W., Et al., Markers of inflammation and cardiovascular disease. Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association, Circulation, 107, pp. 499-511, (2003)
[9]
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice, Eur J Cardiovasc Prev Rehabil, 10, SUPPL. 1, (2003)
[10]
Pepys M.B., CRP or not CRP? That is the question, Arterioscler Thromb Vasc Biol, 25, pp. 1091-1094, (2005)